A detailed history of Zimmer Partners, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Zimmer Partners, LP holds 6,450 shares of LLY stock, worth $5.13 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
6,450
Previous 30,210 78.65%
Holding current value
$5.13 Million
Previous $27.4 Million 79.11%
% of portfolio
0.11%
Previous 0.53%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $18.3 Million - $22.8 Million
-23,760 Reduced 78.65%
6,450 $5.71 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $3.85 Million - $4.83 Million
5,310 Added 21.33%
30,210 $27.4 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $14.7 Million - $19.7 Million
24,900 New
24,900 $19.4 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $1.61 Million - $1.87 Million
5,000 New
5,000 $1.83 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Zimmer Partners, LP Portfolio

Follow Zimmer Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Zimmer Partners, LP with notifications on news.